Markel Group (MKL) Q2 2020 earnings summary

Executive summary

• Q2 2020 results reflected COVID-19 effects across underwriting, investments and Markel Ventures; quarterly investment gains and comprehensive income improved from Q2 2019.

• Six-month results included a net loss per share and a 103% combined ratio, with pandemic-related underwriting losses and equity-market volatility weighing on performance.

Financial highlights

• Q2 earned premiums were $1.36B vs. $1.20B YoY; Markel Ventures operating revenues were $678.1M vs. $617.2M.

• Q2 net investment gains were $911.2M vs. $425.7M; comprehensive income was $1.09B vs. $623.3M.

• Six-month net investment losses were $770.2M vs. gains of $1.04B; comprehensive loss was $260.4M vs. income of $1.36B.

• Diluted EPS was $65.75 in Q2 vs. $36.07; six-month diluted loss per share was $34.83 vs. earnings of $78.85.

Outlook and guidance

• Entering H2, management expected ongoing COVID-19 uncertainty and planned to focus on controllable factors while preparing for challenges and pursuing marketplace opportunities.